Revolution Medicines, Inc. Annual Nonoperating Income (Expense) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Revolution Medicines, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2018 to 2023.
  • Revolution Medicines, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $19.4M, a 77.4% increase year-over-year.
  • Revolution Medicines, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $86.5M, a 158% increase year-over-year.
  • Revolution Medicines, Inc. annual Nonoperating Income (Expense) for 2023 was $47.3M, a 417% increase from 2022.
  • Revolution Medicines, Inc. annual Nonoperating Income (Expense) for 2022 was $9.15M, a 898% increase from 2021.
  • Revolution Medicines, Inc. annual Nonoperating Income (Expense) for 2021 was $917K, a 57.7% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $47.3M +$38.1M +417% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-26
2022 $9.15M +$8.24M +898% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-26
2021 $917K -$1.25M -57.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 $2.17M +$84K +4.03% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 $2.08M +$3.54M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$1.46M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.